EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeitOpen Access · CC BY 4.0

The diagnostic accuracy of blood biomarkers for sarcopenia, sarcopenic obesity, and osteosarcopenia: a meta-analysis

Abigail N Burton, Safoora Gharibzadeh, Mark P Funnell, Kamlesh Khunti, Emma L Watson, Shukrat O Salisu-Olatunji, Farid Salimi Shojaei, Sara Naderpour, Kassam H Hassam, Thomas J Wilkinson

Archives of Gerontology and Geriatrics · 2026

DOI: 10.1016/j.archger.2026.106286 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Archives of Gerontology and Geriatrics, 2026. Verfasst von Abigail N Burton und 9 weiteren Autor:innen. Beteiligte Einrichtung: NIHR Applied Research Collaboration - East Midlands, Leicester General Hospital, Leicester, UK; Leicester Real World Evidence Unit, Diabetes Research…. Hauptthemen laut MEDLINE: Sarcopenia, Biomarkers, Obesity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, NIHR Leicester Biomedical Research Centre, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Sarcopenia is the accelerated loss of skeletal muscle mass and function associated with ageing. Sarcopenia screening consists of body composition imaging and physical function tests; however, these tests can be burdensome and inconsistent. This review aimed to synthesise the available evidence on the diagnostic accuracy of blood biomarkers for sarcopenia (and related conditions). METHODS: Literature searches were conducted using medical subject headings and words relevant to sarcopenia, biomarkers, and diagnostic accuracy. There were no restrictions on the population. Studies that used correlation or regression analyses, or had no control group, were excluded. Pooled estimates of sensitivity, specificity, and area under the curve (AUC) were calculated. RESULTS: The searches identified 150 studies assessing 170 unique biomarkers, and 20 had sufficient studies for meta-analysis. The serum creatinine-cystatin C ratio (CCR) demonstrated pooled sensitivity of 0.69 (95% CI: 0.63-0.75), specificity of 0.74 (95% CI: 0.69-0.80) and AUC of 0.71 (95% CI: 0.68-0.74) (25 studies). Myostatin (10 studies) and irisin (six studies) had pooled sensitivities of 0.76 (95% CI: 0.61-0.87) and 0.74 (95% CI: 0.56-0.86), specificities of 0.71 (95% CI: 0.65-0.76) and 0.72 (95% CI: 0.60-0.81), and AUCs of 0.72 (95% CI: 0.66-0.79) and 0.72 (95% CI: 0.65-0.78), respectively. The diagnostic accuracy of other identified blood biomarkers varied and ranged from fail to excellent. CONCLUSION: This review provides evidence on the use of biomarkers to diagnose sarcopenia, which can inform the development of targeted screening and intervention in research and practice. The integration of biomarker-based diagnostics offers a critical opportunity to reduce the global burden of sarcopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaBiomarkersObesityHumansSensitivity and SpecificityMyostatinCreatinineCystatin CFibronectins

Stichwörter der Autor:innen

BiomarkerBloodDiagnosisMeta-analysisSarcopeniaSensitivity and specificity

Substanzen

BiomarkersMyostatinCreatinineCystatin CFibronectins

Autor:innen und Institutionen

  • NIHR Applied Research Collaboration - East Midlands, Leicester General Hospital, Leicester, UK; Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leiceste…
  • Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK.
  • NIHR Applied Research Collaboration - East Midlands, Leicester General Hospital, Leicester, UK.
  • NIHR Applied Research Collaboration - East Midlands, Leicester General Hospital, Leicester, UK; NIHR Leicester Biomedical Research Centre, Leicester Diabetes Centre, University of Leicester, Leicester, UK.
  • NIHR Leicester Biomedical Research Centre, Leicester Diabetes Centre, University of Leicester, Leicester, UK; Division of Cardiovascular Sciences, University of Leicester, Leicester, UK; School of Sport, Exercise, and H…
  • NIHR Leicester Biomedical Research Centre, Leicester Diabetes Centre, University of Leicester, Leicester, UK.

Förderung

  • British Heart Foundation
  • NIHR Leicester Biomedical Research Centre
  • Australian Research Council
  • NIHR Imperial Biomedical Research Centre
  • National Institute on Handicapped Research

Zitieren

APA

Burton, A. N., Gharibzadeh, S., Funnell, M. P., Khunti, K., Watson, E. L., Salisu-Olatunji, S. O., Shojaei, F. S., Naderpour, S., Hassam, K. H., & Wilkinson, T. J. (2026). The diagnostic accuracy of blood biomarkers for sarcopenia, sarcopenic obesity, and osteosarcopenia: a meta-analysis. Archives of Gerontology and Geriatrics. https://doi.org/10.1016/j.archger.2026.106286

Vancouver

Burton AN, Gharibzadeh S, Funnell MP, Khunti K, Watson EL, Salisu-Olatunji SO, et al. The diagnostic accuracy of blood biomarkers for sarcopenia, sarcopenic obesity, and osteosarcopenia: a meta-analysis. Archives of Gerontology and Geriatrics. 2026. doi:10.1016/j.archger.2026.106286

BibTeX
@article{Burton2026,
  author = {Burton, Abigail N and Gharibzadeh, Safoora and Funnell, Mark P and Khunti, Kamlesh and Watson, Emma L and Salisu-Olatunji, Shukrat O and Shojaei, Farid Salimi and Naderpour, Sara and Hassam, Kassam H and Wilkinson, Thomas J},
  title = {The diagnostic accuracy of blood biomarkers for sarcopenia, sarcopenic obesity, and osteosarcopenia: a meta-analysis},
  journal = {Archives of Gerontology and Geriatrics},
  year = {2026},
  doi = {10.1016/j.archger.2026.106286}
}
Kostenlos starten →